Skip to main content

Read the latest news about the research studies on Alzheimer's at the Barcelonaβeta Brain Research Center (BBRC).

10 Oct | 2022

The AMYPAD project is successfully completed

The consortium has officially ended its formal operation after six years of joint efforts and collaboration.

30 Jun | 2022

The AMYPAD study performs amyloid PET tests on 840 European participants

The research center of the Pasqual Maragall Foundation, the BBRC, participates in the project, together with seven other European centers.

01 Jul | 2021

The BBRC launches Beta-AARC, a cohort study to identify blood biomarkers from the onset of Alzheimer's

The Beta-AARC cohort study aims to advance the early detection of blood biomarkers that indicate pathophysiological changes related to Alzheimer's in people who experience a subjective deterioration of memory.

19 Mar | 2021

The Alfa Study is already reaping the first fruits for an Alzheimer's-free future

The BBRC and the Pasqual Maragall Foundation publish an animated video to thank the effort of the participants, and of all the people and entities that support the research

05 Feb | 2021

Visits to the new study on the relationship between insomnia and Alzheimer's begin

200 participants from the Alfa + study will participate in Alfa Sleep

09 Jul | 2020

BBRC researchers explain how their projects have progressed during the lockdown

The COVID-19 pandemic has not stopped the scientific activity of the Alzheimer’s Prevention Program

18 May | 2020

BBRC starts a new study on the relationship between insomnia and Alzheimer’s disease

Dr. Oriol Grau explains the goals of the study Alfa Sleep, which will start over the next months.

12 May | 2020

What effects does confinement have on mental and brain health?

BBRC launches a new study to analyze the effects of confinement on mental health and brain

04 Mar | 2020

American philanthropists invest 2M euros to diagnose the early stages of Alzheimer’s disease through a blood test

The Alzheimer’s Drug Discovery Foundation funds the research, thanks to donations from Bill Gates, Jeff Bezos and several other philanthropists.